Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States

Journal of the American Academy of Dermatology
Sareeta R S ParkerN J Korman

Abstract

There are large discrepancies in reported mortality for bullous pemphigoid (BP). We sought to determine the mortality of a large cohort of patients with BP and compare this with age-matched control subjects. Data were collected on 223 patients with a new diagnosis of BP between 1998 and 2003 through our cutaneous immunofluorescence laboratory databases. The mortality of patients with BP was compared with that of age-matched control subjects in the general US population. The 1-, 2-, and 5-year mortality was 0.23 (95% confidence interval=0.18, 0.29), 0.37 (95% confidence interval=0.31, 0.44), and 0.50 (95% confidence interval=0.42, 0.57), respectively. However, relative to age-matched control subjects, no difference in expected mortality was detected. This was a retrospective cohort analysis. Mortality of patients with BP is more likely related to advanced age and associated medical conditions than to disease-specific factors.

References

Aug 1, 1977·Archives of Dermatology·A R AhmedT T Provost
Apr 29, 1998·Archives of Dermatology·J C RoujeauP Bernard
Oct 8, 1998·Archives of Dermatology·N J Korman
Feb 1, 2002·The New England Journal of Medicine·Pascal JolyUNKNOWN Bullous Diseases French Study Group
May 14, 2004·The Journal of Investigative Dermatology·Rand L ColbertJanet A Fairley
May 14, 2004·The Journal of Investigative Dermatology·Robert A Swerlick, Neil J Korman
Mar 2, 2005·The Journal of Investigative Dermatology·Jean-Claude Bystryn, Jennifer L Rudolph
Jun 22, 2005·Archives of Dermatology·Pascal JolyJean Claude Roujeau

❮ Previous
Next ❯

Citations

Jun 17, 2014·Journal of the American Academy of Dermatology·Ji Hye Lee, Soo-Chan Kim
Feb 3, 2016·Annales de dermatologie et de vénéréologie·V ChevalierP Bernard
May 9, 2012·Immunology and Allergy Clinics of North America·Enno SchmidtLuca Borradori
Sep 20, 2011·Dermatologic Clinics·Benjamin S DanielDédée F Murrell
May 25, 2011·Dermatologic Clinics·Enno SchmidtLuca Borradori
Dec 15, 2010·Clinics in Dermatology·Sareeta R S Parker, Jamie MacKelfresh
Dec 17, 2009·Annales de dermatologie et de vénéréologie·N CordelUNKNOWN la Société de dermatologie de la Guadeloupe
May 16, 2009·Annales de dermatologie et de vénéréologie·V Doffoel-HantzC Bédane
Mar 19, 2009·Journal of the American Academy of Dermatology·Daniel J Hogan
Mar 16, 2012·The Journal of Investigative Dermatology·Pascal JolyJacques Bénichou
Oct 15, 2010·The Journal of Investigative Dermatology·Sylvie Bastuji-GarinUNKNOWN French Study Group for Bullous Diseases
Jul 2, 2009·The British Journal of Dermatology·G MarazzaUNKNOWN Autoimmune bullous disease Swiss study group
Aug 18, 2009·The British Journal of Dermatology·S M LanganJ West
Dec 21, 2011·International Journal of Dermatology·Maryam DaneshpazhoohZahra Safai-Naraghi
May 18, 2011·The British Journal of Dermatology·B CortésUNKNOWN Autoimmune Bullous Disease Swiss Study Group
Oct 17, 2012·International Journal of Dermatology·Akerke T BaibergenovaNeil H Shear
Jun 21, 2014·The British Journal of Dermatology·P Bernard
Jan 3, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·A GualP Iranzo
Apr 8, 2014·Journal of the American Academy of Dermatology·Katherine E BrickCarilyn N Wieland
Sep 20, 2011·Autoimmunity·Michael KasperkiewiczEnno Schmidt
Mar 11, 2015·Journal of the American Academy of Dermatology·Yee Wei PhoonHaur Yueh Lee
Jul 17, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·J H LeeS-C Kim
Jul 28, 2016·The Journal of Investigative Dermatology·Franziska HübnerEnno Schmidt
May 10, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·B SimH Y Lee
Jun 16, 2018·The Journal of Dermatology·Khalaf KridinShira Zelber-Sagi
Dec 18, 2010·Stroke; a Journal of Cerebral Circulation·Ya-Wen YangHerng-Ching Lin
Jan 10, 2019·JAMA Dermatology·Khalaf Kridin, Reuven Bergman
Nov 2, 2018·Archives of Dermatological Research·Mati RozenblatMichael Ziv
Oct 12, 2010·The Cochrane Database of Systematic Reviews·Gudula KirtschigNonhlanhla P Khumalo
Feb 2, 2018·Annals of Dermatology·Hyeon Woo JeonJee-Bum Lee
Mar 21, 2017·Archives of Dermatological Research·Yi-Di LiuLi Li
Nov 2, 2017·International Journal of Dermatology·Khalaf Kridin, Reuven Bergman
Aug 31, 2017·Archives of Dermatological Research·Agnieszka Kalinska-BieniasKatarzyna Wozniak
Mar 16, 2012·Journal of Cutaneous Medicine and Surgery·Farheen MussaniCheryl F Rosen
Mar 15, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·B MonshiK Rappersberger
Nov 7, 2012·Southern Medical Journal·Chang R NaDaniel G Federman
Jul 6, 2017·Experimental Dermatology·Anna-Kaisa FörstiKaisa Tasanen
Oct 31, 2020·Medicine·Nuntouchaporn Amonchaisakda, Kumpol Aiempanakit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.